Valuation: Ono Pharmaceutical Co., Ltd.

Market Cap 1,166B 7.35B 6.29B 5.87B 5.38B 10.12B 703B 10.32B 69.61B 27.13B 352B 27.58B 26.98B P/E 2027 *
16.2x
P/E 2028 * 18.5x
Enterprise Value 965B 6.08B 5.2B 4.86B 4.46B 8.37B 582B 8.54B 57.6B 22.46B 291B 22.82B 22.33B EV / Sales 2027 *
2.11x
EV / Sales 2028 * 2.05x
Free-Float
80.98%
Yield 2027 *
3.16%
Yield 2028 * 3.12%
07-31 Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 MT
07-30 Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-28 Ono Pharmaceutical Co., Ltd. Partners with Phylo, Inc. to Embed Agentic AI with Every Discovery Scientist CI
06-19 Mizuho Securities Upgrades Ono Pharmaceutical to Buy from Neutral; Price Target is 3,200 Yen MT
06-18 Ono Pharmaceutical to Dispose of 47 Million Yen Treasury Shares Under Stock Compensation Plan MT
06-01 Ono Pharmaceutical Co., Ltd. Announces Oral Presentation Of New Data From The Phase 2 Clinical Study Of ONO-4578 In Certain Gastric Cancers At The ASCO 2026 Annual Meeting CI
05-29 Jefferies Adjusts Ono Pharmaceutical's Price Target to 2,500 Yen From 1,750 Yen, Keeps at Hold MT
05-08 Ono Pharmaceutical's Attributable Profit Jumps 39% in Fiscal Year 2025 MT
05-07 Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-07 Ono Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027 CI
05-07 Ono Pharmaceutical Co., Ltd. Proposes Year End Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 19, 2026 and Provides Dividend Forecasts for the Second Quarter of Year Ending March 31, 2027 and Fiscal Year Ending March 31, 2027 CI
04-22 Top Midday Stories: GE Vernova Shares Gain on Strong Q1 Earnings, Guidance; Vertiv Lifts Guidance After Q1 EPS, Revenue Beats, Shares Fall MT
04-22 Merck, Rivals Show Interest in Inhibrx's Experimental Cancer Drug MT
1 day-1.35%
1 week+0.74%
Current month+2.68%
1 month+2.13%
3 months+0.08%
6 months-6.85%
Current year+12.68%
1 week 2,396
Extreme 2396
2,499
1 month 2,264.5
Extreme 2264.5
2,514.5
Current year 2,114.5
Extreme 2114.5
2,674.5
1 year 1,596
Extreme 1596
2,674.5
3 years 1,474
Extreme 1474
2,966.5
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 67 2024-03-31
Director of Finance/CFO - 2026-03-31
President 57 2024-03-31
Director TitleAgeSince
Chairman 67 2024-03-31
Director/Board Member 57 2020-05-31
Director/Board Member 77 2018-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%+0.74%+47.03%-11.93% 7.35B
-0.08%-1.43%+15.99%+67.26% 47.74B
-3.21%+1.37%+52.36%+125.75% 41.7B
-0.40%-1.23%-10.08%+16.08% 12.14B
+1.11%-1.34%+13.61%+71.49% 11.55B
0.00%0.00%+30.00%+147.62% 9.18B
-0.39%+0.62%+19.93%+39.54% 7.54B
-0.64%-0.02%+19.42%+199.06% 6.88B
+2.65%-3.55%-31.27%+24.03% 5.72B
-0.51%-0.90%+37.01%+103.41% 4.78B
Average -0.28%-0.44%+19.40%+78.23% 15.46B
Weighted average by Cap. -0.87%-0.49%+25.13%+84.37%

Financials

2027 *2028 *
Net sales 457B 2.88B 2.46B 2.3B 2.11B 3.96B 275B 4.04B 27.28B 10.63B 138B 10.81B 10.57B 447B 2.82B 2.41B 2.25B 2.06B 3.88B 270B 3.96B 26.7B 10.41B 135B 10.58B 10.35B
Net income 72.16B 455M 389M 363M 333M 626M 43.49B 638M 4.31B 1.68B 21.8B 1.71B 1.67B 63.11B 398M 340M 318M 291M 548M 38.04B 558M 3.77B 1.47B 19.06B 1.49B 1.46B
Net Debt -201B -1.27B -1.08B -1.01B -928M -1.74B -121B -1.78B -12B -4.68B -60.74B -4.76B -4.65B -250B -1.57B -1.35B -1.26B -1.15B -2.17B -150B -2.21B -14.91B -5.81B -75.42B -5.91B -5.78B
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
26-08-21 JP¥2,448.00 -1.35% 1,467,200
26-08-20 JP¥2,481.50 +0.87% 1,548,800
26-08-19 JP¥2,460.00 +0.80% 1,595,900
26-08-18 JP¥2,440.50 +1.33% 1,426,700
26-08-17 JP¥2,408.50 -0.88% 1,556,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,481.50JPY
Average target price
2,508.33JPY
Spread / Average Target
+1.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4528 Stock